跳至主要内容
临床试验/JPRN-jRCT2031220410
JPRN-jRCT2031220410招募中2 期

A phase II study of boron neutron capture therapy (BNCT) for patients with unresectable angiosarcoma, by using CICS-1 and SPM-011

Hayashi Toshimitsu0 个研究点目标入组 10 人开始时间: 2022年10月26日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 85age old(—)
性别
All

入选标准

  • Written informed consent must be obtained from the subject.
  • - Histologically documented primary skin angiosarcoma.
  • - Locally advanced or locally recurrent angiosarcoma, and not eligible for curative surgery, chemoradiotherapy or radiotherapy. (Including cases where the individual refuses treatment.)
  • - Measurable disease, as defined by RECIST v1.1.
  • - The longest diameter of the entire target lesion is 15 cm or less.
  • - ECOG performance status score of Grade 0 to 2

排除标准

  • - Apparent disseminated tumor lesions.
  • - Hereditary fructose intolerance.
  • - Phenylketonuria.
  • - Any serious concomitant disease that precludes completion of the study treatment.
  • - The target lesion has received radiation exceeding 75 Gy.

研究者

发起方
Hayashi Toshimitsu

相似试验